Literature DB >> 31548122

Do Alzheimer's and Lewy body disease have discrete pathological signatures of gait?

Ríona Mc Ardle1, Brook Galna2, Paul Donaghy1, Alan Thomas1, Lynn Rochester3.   

Abstract

OBJECTIVE: We aimed to refine the hypothesis that dementia has a unique signature of gait impairment reflective of underlying pathology by considering two dementia subtypes, Alzheimer's disease (AD) and Lewy body disease (LBD), and exploring the role of cognition in disease-specific gait impairments.
BACKGROUND: Accurately differentiating AD and LBD is important for treatment and disease management. Early evidence suggests gait could be a marker of dementia due to associations between discrete gait characteristics and cognitive domains. UPDATED HYPOTHESIS: We hypothesize that AD and LBD have unique signatures of gait, reflecting disease-specific cognitive profiles and underlying pathologies. An exploratory study included individuals with mild cognitive impairment or dementia due to LBD (n = 45) and AD (n = 36) and 29 older adult controls. An instrumented walkway quantified 16 gait characteristics reflecting five independent domains of locomotion (pace, rhythm, variability, asymmetry, and postural control). The LBD group demonstrated greater impairments in asymmetry and variability compared with AD; both groups were more impaired in pace and variability domains than controls. Executive dysfunction explained 11% of variance for gait variability in LBD, whereas global cognitive impairment explained 13.5% of variance in AD; therefore, gait impairments may reflect disease-specific cognitive profiles. With a refined hypothesis that AD- and LBD-specific signatures of gait reflect discrete pathologies, future studies must examine the relationship between a validated model of gait with neural networks, using recognized biomarkers and postmortem follow-up. MAJOR CHALLENGES FOR HYPOTHESIS: Differential diagnosis of AD and LBD used appropriate criteria and required consensus from an expert diagnostic panel to improve diagnostic accuracy. Future work should follow the framework set out in Parkinson's disease to establish unique signatures of gait as proxy measures of disease-specific pathology; that is, use a validated gait model to explore the progressive relationship between gait, cognition, and pathology. LINKAGE TO OTHER MAJOR THEORIES: These exploratory findings support the theory of interacting cognitive-motor networks, as the gait-cognition relationship may reflect cognitive control over motor networks. Unique signatures of gait may reflect different temporal patterns of pathological burden in neural areas related to cognitive and motor function.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cognition; Differential diagnosis; Gait analysis; Lewy body disease

Year:  2019        PMID: 31548122     DOI: 10.1016/j.jalz.2019.06.4953

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  8 in total

1.  Spatio-temporal gait parameters obtained from foot-worn inertial sensors are reliable in healthy adults in single- and dual-task conditions.

Authors:  J Soulard; J Vaillant; R Balaguier; N Vuillerme
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

2.  The Impact of Environment on Gait Assessment: Considerations from Real-World Gait Analysis in Dementia Subtypes.

Authors:  Ríona Mc Ardle; Silvia Del Din; Paul Donaghy; Brook Galna; Alan J Thomas; Lynn Rochester
Journal:  Sensors (Basel)       Date:  2021-01-26       Impact factor: 3.576

3.  Continuous gait monitoring discriminates community-dwelling mild Alzheimer's disease from cognitively normal controls.

Authors:  Vijay R Varma; Rahul Ghosal; Inbar Hillel; Dmitri Volfson; Jordan Weiss; Jacek Urbanek; Jeffrey M Hausdorff; Vadim Zipunnikov; Amber Watts
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-05

4.  Balance Impairments as Differential Markers of Dementia Disease Subtype.

Authors:  Ríona Mc Ardle; Stephanie Pratt; Christopher Buckley; Silvia Del Din; Brook Galna; Alan Thomas; Lynn Rochester; Lisa Alcock
Journal:  Front Bioeng Biotechnol       Date:  2021-03-11

5.  Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Yasunori Yamada; Kaoru Shinkawa; Masatomo Kobayashi; Vittorio Caggiano; Miyuki Nemoto; Kiyotaka Nemoto; Tetsuaki Arai
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.

Authors:  Masatomo Kobayashi; Yasunori Yamada; Kaoru Shinkawa; Miyuki Nemoto; Kiyotaka Nemoto; Tetsuaki Arai
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

7.  The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease.

Authors:  Maria Angeles Prats-Sedano; George Savulich; Ajenthan Surendranathan; Paul C Donaghy; Alan J Thomas; James B Rowe; Li Su; John T O'Brien
Journal:  Int J Geriatr Psychiatry       Date:  2020-12-14       Impact factor: 3.850

8.  Wearable Inertial Measurement Units for Assessing Gait in Real-World Environments.

Authors:  David Renggli; Christina Graf; Nikolaos Tachatos; Navrag Singh; Mirko Meboldt; William R Taylor; Lennart Stieglitz; Marianne Schmid Daners
Journal:  Front Physiol       Date:  2020-02-20       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.